| Serial Number | 79416326 |
| Word Mark | HYSORPTASE |
| Filing Date | Monday, November 11, 2024 |
| Status | 681 - PUBLICATION/ISSUE REVIEW COMPLETE |
| Status Date | Tuesday, September 9, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, September 30, 2025 |
| Goods and Services | Medicines for human purposes for treating autoimmune diseases, organ transplant rejection, organ failure, genetic diseases, tumors, cancer, infertility, metabolic conditions and disorders, endocrine conditions and disorders, diabetes, diabetic complications, hormonal diseases and disorders, skin disorders; pharmaceutical preparations for treating autoimmune diseases, organ transplant rejection, organ failure, genetic diseases, tumors, cancer, infertility, metabolic conditions and disorders, endocrine conditions and disorders, diabetes, diabetic complications, hormonal diseases and disorders, skin disorders; drugs for medical purposes for treating autoimmune diseases, organ transplant rejection, organ failure, genetic diseases, tumors, cancer, infertility, metabolic conditions and disorders, endocrine conditions and disorders, diabetes, diabetic complications, hormonal diseases and disorders, skin disorders; biological preparations for use in cell cultures for medical purposes; enzymes for medical purposes; enzyme preparations for medical purposes; adjuvants for medical purposes; injectable solutions for medical purposes, namely, hyaluronidase in injectable form; aqueous solutions for medical purposes containing recombinant human hyaluronidase for subcutaneous delivery that facilitate the delivery of pharmaceutical preparations; biochemical drugs for treating autoimmune diseases, organ transplant rejection, organ failure, genetic diseases, tumors, cancer, infertility, metabolic conditions and disorders, endocrine conditions and disorders, diabetes, diabetic complications, hormonal diseases and disorders, skin disorders |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Thursday, February 6, 2025 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Shanghai Bao Pharmaceuticals Co.,Ltd. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | CN |
| Event Date | Event Description |
| Thursday, February 6, 2025 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Saturday, February 8, 2025 | APPLICATION FILING RECEIPT MAILED |
| Tuesday, April 15, 2025 | ASSIGNED TO EXAMINER |
| Saturday, February 8, 2025 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, April 21, 2025 | NON-FINAL ACTION WRITTEN |
| Sunday, June 22, 2025 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Saturday, July 12, 2025 | REFUSAL PROCESSED BY IB |
| Monday, August 25, 2025 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
| Tuesday, April 22, 2025 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Saturday, June 21, 2025 | REFUSAL PROCESSED BY MPU |
| Monday, August 25, 2025 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Monday, August 25, 2025 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
| Tuesday, August 26, 2025 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, August 26, 2025 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Tuesday, August 26, 2025 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, August 29, 2025 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Monday, August 25, 2025 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |